“…As regards the role of WS in determining weight gain, this article is consistent with several valuable pieces of research clearly showing that WS predicts weight gain during and after treatment (Berner et al, 2013;Bodell, Racine, & Wildes, 2016;Carter et al, 2015;Wildes & Marcus, 2012) in AN (and restricting AN) and in BN (Brewerton et al, 2000;Herzog et al, 2010;Hessler et al, 2018;Lowe et al, 2006), which may be only partially because of lower energy expenditure and resting metabolic rate in the presence of high WS (Stice, Durant, Burger, & Schoeller, 2011), or to leptin (Bodell & Keel, 2015;Keel, Bodell, Haedt-Matt, Williams, & Appelbaum, 2017). Moreover consistently with the present study, several studies have shown that WS may not be associated with treatment outcome such as binge/purge abstinence, response, remission, in patients with BN (Carter et al, 2008;Dawkins et al, 2013;Zunker et al, 2011), nor with treatment compliance or drop-out rates (Carter et al, 2008).…”